Issue 30, 2016

A drug release switch based on protein-inhibitor supramolecular interaction

Abstract

In this report, we describe a new system in which mesoporous silica nanoparticles (MSNs) are gated with α-chymotrypsin A protein (CTRA) and the cargoes within the vehicles are released in the presence of phenylmethanesulfonyl fluoride (PMSF), a canonical inhibitor of CTRA. This cargo release switch is based on the specific interaction between CTRA and PMSF as well as structural changes upon their supramolecular complex formation. This host–guest gating system works smoothly both in vitro and within cells. This type of bio-switch may be extended to other drug carrier systems by using diverse protein–inhibitor pairs that exist in nature.

Graphical abstract: A drug release switch based on protein-inhibitor supramolecular interaction

Supplementary files

Article information

Article type
Paper
Submitted
07 Feb 2016
Accepted
01 Mar 2016
First published
02 Mar 2016

RSC Adv., 2016,6, 25480-25484

A drug release switch based on protein-inhibitor supramolecular interaction

X. Wang, P. Liu, Z. Chen and J. Shen, RSC Adv., 2016, 6, 25480 DOI: 10.1039/C6RA03543D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements